loadpatents
Patent applications and USPTO patent grants for Gunawan; Iwan.The latest application filed is for "substituted benzoxazoles as estrogenic agents".
Patent | Date |
---|---|
Substituted benzoxazoles as estrogenic agents Grant 7,531,564 - Malamas , et al. May 12, 2 | 2009-05-12 |
Substituted benzoxazoles as estrogenic agents App 20070167503 - Malamas; Michael S. ;   et al. | 2007-07-19 |
Substituted benzoxazoles as estrogenic agents Grant 7,148,247 - Malamas , et al. December 12, 2 | 2006-12-12 |
Substituted benzoxazoles as estrogenic agents Grant 7,129,258 - Malamas , et al. October 31, 2 | 2006-10-31 |
Naphthyl benzoxazoles and benzisoxazoles as estrogenic agents App 20050272786 - Malamas, Michael S. ;   et al. | 2005-12-08 |
Naphthyl benzoxazoles and benzisoxazoles as estrogenic agents Grant 6,960,607 - Malamas , et al. November 1, 2 | 2005-11-01 |
Substituted benzoxazoles as estrogenic agents App 20050239851 - Malamas, Michael S. ;   et al. | 2005-10-27 |
Phenyl benzisoxazoles as estrogenic agents App 20050159465 - Malamas, Michael S. ;   et al. | 2005-07-21 |
Phenyl benzisoxazoles as estrogenic agents Grant 6,884,814 - Malamas , et al. April 26, 2 | 2005-04-26 |
Substituted benzoxazoles as estrogenic agents App 20050080117 - Malamas, Michael S. ;   et al. | 2005-04-14 |
Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia Grant 6,844,358 - Malamas , et al. January 18, 2 | 2005-01-18 |
Substituted benzoxazoles as estrogenic agents Grant 6,794,403 - Malamas , et al. September 21, 2 | 2004-09-21 |
Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia App 20040102480 - Malamas, Michael S. ;   et al. | 2004-05-27 |
Phenyl benzisoxazoles as estrogenic agents App 20030207927 - Malamas, Michael S. ;   et al. | 2003-11-06 |
Substituted benzoxazoles as estrogenic agents App 20030199562 - Malamas, Michael S. ;   et al. | 2003-10-23 |
Naphthyl benzoxazoles and benzisoxazoles as estrogenic agents App 20030171412 - Malamas, Michael S. ;   et al. | 2003-09-11 |
Azolidines as beta-3 adrenergic receptor agonists App 20030055079 - Malamas, Michael Sotirios ;   et al. | 2003-03-20 |
Azolidines as beta-3 adrenergic receptor agonists App 20020032222 - Malamas, Michael S. ;   et al. | 2002-03-14 |
Amino-thiazolidinediones useful in the treatment of insulin resistance and hyperglycemia Grant 6,214,842 - Malamas , et al. April 10, 2 | 2001-04-10 |
Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia Grant 6,166,069 - Malamas , et al. December 26, 2 | 2000-12-26 |
Aryl-n-hydroxyureas as inhbitors of 5-lipoxygenase and anti-arteriosclerotic agents Grant 5,541,205 - Malamas , et al. July 30, 1 | 1996-07-30 |
New azolidinediones and thiadiazolidinediones as antihyperglycemic agents Grant 5,532,256 - Malamas , et al. July 2, 1 | 1996-07-02 |
Aralkyl-1,2,4-oxadiazolidine-3,5-diones as antihyperglycemic agents Grant 5,480,896 - Malamas , et al. January 2, 1 | 1996-01-02 |
Azolidinediones as antihyperglycemic agents Grant 5,468,762 - Malamas , et al. November 21, 1 | 1995-11-21 |
Aryl-N-hydroxyureas as inhibitors of 5-lipoxygenase and anto-arteriosclerotic agents Grant 5,428,048 - Malamas , et al. June 27, 1 | 1995-06-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.